Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0000880984-22-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-01 | 2022-11-29+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.50 | -22.2K | 9.63M | -0.2% | -$33.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock | 2022-11-29 | S | D | 13,730 | $1.50 | 9,643,234 | I by Glytech LLC | — | — | (F2) Held by Glytech LLC of which the Reporting Person is the sole owner. |
| 2 | Common | common stock | 2022-11-30 | S | D | 8,441 | $1.50 | 9,634,793 | I by Glytech LLC | — | — | (F2) Held by Glytech LLC of which the Reporting Person is the sole owner. |